HST-NEETs

BIOLOGICAL2 trials

Sponsors

Catherine Bollard

Conditions

HIV Associated LymphomaHIV Infections

Phase 1

HIV-1 Specific T -Cells (HST-NEETs) for HIV-Infected Individuals

CompletedNCT03485963

Catherine BollardHIV Infections

Start: 2019-03-21End: 2022-06-21Updated: 2025-04-29

Phase 2

HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903

CompletedNCT04975698

Catherine BollardHIV Associated Lymphoma

Start: 2021-10-25End: 2026-01-05Updated: 2026-06-29

Related Papers

Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 study

Nature Communications2025-05-153 citations

Phase I Study Evaluating Outcomes of Autologous HIV-Specific T Cells Targeting Non-Escaped Epitopes (HST-NEET) Therapy in HIV+ Individuals on ART (NCT03485963)

Blood2022-11-151 citations